On Monday, Tesla sent an email to employees saying it was laying off around 10 percent of its workforce, or roughly 14,000 ...
Drugmakers and other health-focused companies are laying off hundreds of Bay Area workers, collectively, all close to the ...
Rivian said the latest round of cuts affect about 1% of its workforce.
Amgen's stock isn't expensive, but the business does face some challenges, which could have investors thinking twice.
Boehringer Ingelheim on Thursday said it will lay off some of its U.S. salesforce due to poor sales there of its biosimilar ...
Tesla plans to lay off more than 10% of its employees, multiple news outlets report, as the electric vehicle maker continues ...
Novartis plans to cut as many as 680 jobs in development, Sanofi's pipeline reprioritization project will result in layoffs.
After reporting dismal first-quarter sales, Tesla is planning to lay off about a tenth of its workforce as it tries to cut ...
Eli Lilly's stock has seen significant growth due to the success of its obesity drug, "Zepbound," but its high valuation and upcoming competition make it less attractive. Amgen, with its obesity ...
Amgen has been struggling to grow its revenue at a good clip organically. The company's pipeline and a recent acquisition should help it improve. The biotech is an excellent stock for income ...
Two of Elon Musk’s top deputies are also departing the world’s most valuable automaker.
Biotech giant Amgen (NASDAQ: AMGN) isn't starting the year on a strong note. The company's shares are down by 5% since Jan. 1. It has dealt with some issues lately, especially subpar financial ...